The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa

AIDS

Volumn 26, Issue SUPPL.1, 2012, Pages

  Hontelez, Jan A C ^a,b,c   De Vlas, Sake J ^a   Baltussen, Rob ^b   Newell, Marie Louise ^c   Bakker, Roel ^a   Tanser, Frank ^c   Lurie, Mark ^d   Bärnighausen, Till ^c,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d BROWN UNIVERSITY   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

aging; antiretroviral therapy; epidemiological trends; HIV; mathematical model

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTITUTION; SEXUAL BEHAVIOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGING; ANTI-HIV AGENTS; EPIDEMICS; FEMALE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LIFE EXPECTANCY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MODELS, THEORETICAL; PREVALENCE; YOUNG ADULT;

EID: 84863843550     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283558526     Document Type: Article

References (66)

1. WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector; progress report 2010. Geneva: World Health Organization; 2010.
2. UN. High level meeting on AIDS. New York: United Nations General Assembly; 2011.
3. Negin J, Mills EJ, Albone R. Continued neglect of ageing of HIV epidemic at UN meeting. Lancet 2011; 378:768.
4. Herbst AJ, Cooke GS, Bärnighausen T, KanyKany A, Tanser F, Newell ML. Adult mortality and antiretroviral treatment rollout in rural KwaZulu-Natal, South Africa. Bull World Health Organ 2009; 87:754-762.
5. Mills EJ, Bakanda C, Birungi J, Mwesigwa R, Chan K, Ford N, et al. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS 2011; 25:851-855.
6. Mutevedzi PC, Lessells RJ, Rodger AJ, Newell ML. Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults. PLoS One 2011; 6:e21795.
7. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1397-1404.
8. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
9. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375:2092-2098.
10. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010; 376:532-539.
11. CDC. HIV/AIDS surveillance report 2008. Vol. 20. Atlanta: Centers for Disease Control and Prevention; 2010.
12. Hontelez JA, Lurie MN, Newell ML, Bakker R, Tanser F, Bärnighausen T, et al. Ageing with HIV in South Africa. AIDS 2011; 25:1665-1667.
13. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ 2010; 88:847-853.
14. UNAIDS. Report on the global AIDS epidemic 2010. Geneva: UNAIDS; 2010.
15. Hontelez J, de Vlas S, Tanser F, Bakker R, Bärnighausen T, Newell M, et al. The Impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS One 2011; 6:e21919.
16. Korenromp EL, Bakker R, Gray R, Wawer MJ, Serwadda D, Habbema JD. The effect of HIV, behavioural change, and STD syndromic management on STD epidemiology in sub-Saharan Africa: simulations of Uganda. Sex Transm Infect 2002; 78 (Suppl 1):i55-i63. (Pubitemid 34548000)
17. van der Ploeg CPB, Van Vliet C, De Vlas SJ, Ndinya-Achola JO, Fransen L, van Oortmarssen GJ, et al. STDSIM: a microsimulation model for decision support in STD control. Interfaces 1998; 28:84-100.
18. UN. World fertility data 2008. Geneva: Fertility and Family Planning Section, United Nations Population Division; 2008.
19. WHO. Life tables for WHO member states. Geneva: World Health Organization; 2011.
20. WHO. The global burden of disease 2004. Update 2008. Geneva: World Health Organization; 2011.
21. Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, et al. The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med 2006; 3:e262.
22. Ghys PD, Zaba B, Prins M. Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network. AIDS 2007; 21 (Suppl 6): S1-S4. (Pubitemid 350158882)
23. Korenromp EL, Van Vliet C, Bakker R, De Vlas SJ, Habbema JD. HIV spread and partnership reduction for different patterns of sexual behavior: a study with the microsimulation model STDSIM. Math Pop Studies 2000; 8:135-173. (Pubitemid 32334055)
24. Orroth KK, Freeman EE, Bakker R, Buve A, Glynn JR, Boily MC, et al. Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect 2007; 83 (Suppl 1):i5-i16. (Pubitemid 47242467)
25. Steele KT, Steenhoff AP, Newcomb CW, Rantleru T, Nthobatsang R, Lesetedi G, et al. Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana. PLoS One 2011; 6:e20010.
26. Musiime S, Muhairwe F, Rutagengwa A, Mutimura E, Anastos K, Hoover DR, et al. Adherence to highly active antiretroviral treatment in HIV-infected Rwandan women. PLoS One 2011; 6:e27832.
27. Van der Veen F, Mugala-Mukungu F, Kangudi M, Feris A, Katjitae I, Colebunders R. Antiretroviral treatment in the private sector in Namibia. Int J STD AIDS 2011; 22:577-580.
28. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007; 4:e298.
29. Mosoko JJ, Akam W, Weidle PJ, Brooks JT, Aweh AJ, Kinge TN, et al. Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon. J Int AIDS Soc 2011; 14:32.
30. Buve A, Carael M, Hayes RJ, Auvert B, Ferry B, Robinson NJ, et al. Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection. AIDS 2001; 15 (Suppl 4):S5-S14. (Pubitemid 32913000)
31. Wallrauch C, Bärnighausen T, Newell ML. HIV prevalence and incidence in people 50 years and older in rural South Africa. S Afr Med J 2010; 100:812-814.
32. Statement on the meeting of the South African National AIDS Council (SANAC), 12 August 2011. Accessed on 10 June 2012; available at http://www.thepresidency.gov.za/pebble.asp? relid4650.
33. UN. World population prospects, the 2010 revision. Geneva: United Nations Population Division; 2010.
34. Bärnighausen T, Welz T, Hosegood V, Batzing-Feigenbaum J, Tanser F, Herbst K, et al. Hiding in the shadows of the HIV epidemic: obesity and hypertension in a rural population with very high HIV prevalence in South Africa. J Hum Hypertens 2008; 22:236-239. (Pubitemid 351266498)
35. Beaglehole R, Bonita R, Alleyne G, Horton R. NCDs: celebrating success, moving forward. Lancet 2011; 378:1283-1284.
36. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al. UN high-level meeting on non-communicable diseases: addressing four questions. Lancet 2011; 378:449-455.
37. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the noncommunicable disease crisis. Lancet 2011; 377:1438-1447.
38. Mbanya JC, Squire SB, Cazap E, Puska P. Mobilising the world for chronic NCDs. Lancet 2011; 377:536-537.
39. Dalal S, Beunza JJ, Volmink J, Adebamowo C, Bajunirwe F, Njelekela M, et al. Noncommunicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol 2011; 40:885-901.
40. Thorogood M, Connor M, Tollman S, Lewando Hundt G, Fowkes G, Marsh J. A cross-sectional study of vascular risk factors in a rural South African population: data from the Southern African Stroke Prevention Initiative (SASPI). BMC Public Health 2007; 7:326.
41. Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D, et al. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study 'Heart Awareness Days'. Int J Cardiol 2009; 132:233-239.
42. Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne ML. Implications of mortality transition for primary healthcare in rural South Africa: a population-based surveillance study. Lancet 2008; 372:893-901.
43. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 2011; 11:564.
44. Kirk JB, Goetz MB. Human immunodeficiency virus in an aging population, a complication of success. J Am Geriatr Soc 2009; 57:2129-2138.
45. Kearney F, Moore AR, Donegan CF, Lambert J. The ageing of HIV: implications for geriatric medicine. Age Ageing 2010; 39:536-541.
46. Schmid GP, Williams BG, Garcia-Calleja JM, Miller C, Segar E, Southworth M, et al. The unexplored story of HIV and ageing. Bull World Health Organ 2009; 87:162-1162.
47. Justice AC. HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep 2010; 7:69-76.
48. Stewart F, Yermo J. Pensions in Africa, OECD Working Papers on Insurance and Private Pensions, No. 30. Paris: OECD Publishing. 2009. doi:10.1787/ 227444006716.
49. Kautz T, Bendavid E, Bhattacharya J, Miller G. AIDS and declining support for dependent elderly people in Africa: retrospective analysis using demographic and health surveys. Brit Med J 2010; 340:c2841.
50. Bärnighausen T, Bloom DE, Humair S. Universal antiretroviral treatment: the challenge of human resources. Bull World Health Organ 2010; 88:951-952.
51. Voelker R. HIV/AIDS funding dropped by 10% in 2010. JAMA 2011; 306:1642-1643.
52. Schwartlander B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011; 377:2031-2041.
53. Hontelez JA, Nagelkerke N, Bärnighausen T, Bakker R, Tanser F, Newell ML, et al. The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine 2011; 29:6100-6106.
54. Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010; 24:621-635.
55. Bärnighausen T, Bloom DE, Humair S. Going horizontal: shifts in funding of global health interventions. N Engl J Med 2011; 364:2181-2183.
56. Napierala Mavedzenge S, Olson R, Doyle AM, Changalucha J, Ross DA. The epidemiology of HIV among young people in sub-Saharan Africa: know your local epidemic and its implications for prevention. J Adolesc Health 2011; 49:559-567.
57. Tebit DM, Arts EJ. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect Dis 2011; 11:45-56.
58. Fatti G, Bock P, Eley B, Mothibi E, Grimwood A. Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009. J Acquir Immune Defic Syndr 2011; 58:e60-e67.
59. Boyd M, Emery S, Cooper DA. Antiretroviral roll-out: the problem of second-line therapy. Lancet 2009; 374:185-186.
60. Nagelkerke NJ, Jha P, de Vlas SJ, Korenromp EL, Moses S, Blanchard JF, et al. Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ 2002; 80:89-96. (Pubitemid 34205095)
61. Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, et al. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect Dis 2011; 11:750-759.
62. Manasa J, Katzenstein D, Cassol S, Newell ML, de Oliveira T. Primary drug resistance in South Africa: data from 10 years of surveys. AIDS Res Hum Retroviruses 2012; 28:558-565.
63. Nachega JB, Mills EJ, Schechter M. Antiretroviral therapy adherence and retention in care in middle-income and lowincome countries: current status of knowledge and research priorities. Curr Opin HIV AIDS 2010; 5:70-77.
64. Palacios-Cena D, Carrasco-Garrido P, Hernandez-Barrera V, Alonso-Blanco C, Jimenez-Garcia R, Fernandez-de-Las-Penas C. Sexual behaviors among older adults in Spain: results from a population-based national sexual health survey. J Sex Med 2012; 9:121-129.
65. Drew O, Sherrard J. Sexually transmitted infections in the older woman. Menopause Int 2008; 14:134-135.
66. Mack KA, Ory MG. AIDS and older Americans at the end of the Twentieth Century. J Acquir Immune Defic Syndr 2003; 33 (Suppl 2):S68-S75. (Pubitemid 36801604)